Background The increasing incidence of Kawasaki disease (KD) in the UK is associated with increasing numbers of children with coronary artery aneurysms (CAA) as sequelae (24% of children despite immunoglobulin, IVIG). We wish to determine a system of recognising those at presentation who may need additional therapy since it has been shown that systems in Japan (eg Kobayashi) do not apply to the UK or USA. Methods All children with KD presenting to any hospital in our region over a time period of 16 years were reviewed, presenting from 2001-2017. Only children with postcodes in our region were included, to avoid any sample bias. Demographic and laboratory characteristics were obtained and the correlation with CAA was noted. The data were analysed for sex, age at diagnosis, clinical features of KD and laboratory parameters (full blood count, CRP, liver function tests, albumin, and sodium).
Results 493 children were seen without case selection during this time period. Of these 105 had CAA and 388 did not. The rate of diagnosis increased during the time period, as did the numbers with CAA. Demographic data showed the overall incidence of children with CAA was 22%, two-thirds were male and those with CAA were younger compared to those without: median 823 vs 1478 days, p=0.01. If there was a lower platelet count 323 vs 419×10 9 /L, p=0.02, higher neutrophil count 9.3 vs 6.6×10 6 /L, p=0.0001, and higher CRP 181 vs 102 mg/L, p=0.005, but not serum sodium or liver function tests, these were associated with CAA. It was noted that patients with KD were more likely to come from rural than urban areas. Younger children under 6 months were more likely to have giant aneurysms and to have atypical KD. Conclusions In this large defined catchment area, we have demonstrated risk factors that are typical of children in a UK population. Although not a prospective study, this data suggests those who are most likely to develop CAA and to be resistant to IVIG therapy. More formal analysis is needed to determine if this is consistent with multi-variate analysis but seems a good early indicator. Aims The publication of the pioneering Adverse Childhood Experiences (ACEs) study, 1 has resulted in an increasing body of evidence demonstrating that exposure to ACEs has a significant impact on adult health outcomes. Our aim was to evaluate the level of awareness and enquiry regarding ACEs amongst paediatricians in clinical practice in the UK. Methods An electronic questionnaire was distributed to a sample of hospital and community based paediatricians in practice in the UK. Details of the original ACE study were provided including the 10 ACEs: Conclusion Whilst knowledge of the ACEs study appears to be relatively low amongst the sampled group of UK paediatricians, it is reassuring that enquiry related to specific ACEs is already embedded in clinical practice. This is supported by the presence of an excellent and established range of allied services available for onward referral and definitive management. The American Academy of Paediatrics (AAP) has published a position statement supporting routine screening for ACEs in the USA. 2 This has resulted in a gathering of momentum with an ACE focussed approach to paediatrics supported by the National Paediatric Practice Community (NPPC).
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The findings of this survey represent a significant opportunity. A compelling case is made for child advocacy and an evidence base for sustained investment in all allied services which
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